George Blassan P, Chota Alexander, Sarbadhikary Paromita, Abrahamse Heidi
Laser Research Centre, Faculty of Health Sciences, University of Johannesburg, Johannesburg, South Africa.
Front Chem. 2022 Jul 22;10:964674. doi: 10.3389/fchem.2022.964674. eCollection 2022.
The introduction of nanotechnology in the field of Photodynamic Therapy (PDT) has proven to have great potential to overcome some of the challenges associated with traditional organic photosensitizers (PS) with respect to their solubility, drug delivery, distribution and site-specific targeting. Other focused areas in PDT involve high singlet oxygen production capability and excitability of PS by deep tissue penetrating light wavelengths. Owing to their very promising optical and surface plasmon resonance properties, combination of traditional PSs with plasmonic metallic nanoparticles like gold and silver nanoparticles results in remarkably high singlet oxygen production and extended excitation property from visible and near-infrared lights. This review summarizes the importance, fundamentals and applications of on plasmonic metallic nanoparticles in PDT. Lastly, we highlight the future prospects of these plasmonic nanoengineering strategies with or without PS combination, to have a significant impact in improving the therapeutic efficacy of cancer PDT.
纳米技术在光动力疗法(PDT)领域的引入已被证明具有巨大潜力,能够克服传统有机光敏剂(PS)在溶解度、药物递送、分布和位点特异性靶向方面所面临的一些挑战。PDT的其他重点领域包括单线态氧的高产生能力以及PS对深部组织穿透光波长的激发性。由于其极具前景的光学和表面等离子体共振特性,将传统PS与金和银纳米颗粒等等离子体金属纳米颗粒相结合,可显著提高单线态氧的产生,并扩展可见光和近红外光的激发特性。本综述总结了等离子体金属纳米颗粒在PDT中的重要性、基本原理及应用。最后,我们强调了这些等离子体纳米工程策略(无论是否与PS结合)在提高癌症PDT治疗效果方面产生重大影响的未来前景。